Universal Ibogaine Inc. IBOGF
0.00 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
0.008 Day range 0.008
0.00001 52-week range 0.35
- YTD
- -96.97%
- 1 year
- -98.55%
News
thenewswire.com Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process Calgary, AB – TheNewswire - January 19, 2026 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered…
thenewswire.com Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process Calgary, AB – TheNewswire - January 2, 2026 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered…
thenewswire.com Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process Calgary, AB – TheNewswire - December 18, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered…
thenewswire.com Universal Ibogaine advises further on application for Management Cease Trade Order Calgary, AB – December 2, 2025 – TheNewswire – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized…
thenewswire.com Universal Ibogaine Advises of Filing Application for Management Cease Trade Order Calgary, AB – TheNewswire - November 25, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered…
thenewswire.com Universal Ibogaine Provides Corporate Update Calgary, AB – TheNewswire - October 28, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized…
thenewswire.com Universal Ibogaine Announces Board Changes Calgary, AB – September 23, 2025 – TheNewswire - Universal Ibogaine Inc. (TSXV: IBO) OTC: IBOGF (the “Company”), The Universal Ibogaine Board of directors brings together expertise in healthcare ,…
thenewswire.com Universal Ibogaine Announces Results of the Annual Meeting of Shareholders Calgary, AB – TheNewswire - September 1 4 , 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized…
thenewswire.com Universal Ibogaine Inc. provides update on intent to file Clinical Trial Application with Health Canada and confirms securing of Ibogaine drug supply Calgary, Alberta, September 4, 2025 – TheNewswire - Universal Ibogaine Inc. (TSXV: IBO, in USA: IBOGF, in Germany FSE:JC4) (“ UI ” or the “ Company ) is pleased to announce its intention to file,…
thenewswire.com Universal Ibogaine advises of appointment of two new Board Members Calgary, AB – September 3, 2025 – TheNewswire - Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized…
thenewswire.com Universal Ibogaine advises of departure of CFO Calgary, AB – TheNewswire - July 16, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized…
thenewswire.com Universal Ibogaine Advises of Debt Settlement with CEO and Resignation of a Member of its Board of Directors Calgary, AB – TheNewswire - J uly 7, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized…
thenewswire.com Universal Ibogaine Advises of Debt Settlement Agreement and Update on Status of Cease Trade Order Calgary, AB – TheNewswire - April 3, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction…
proactiveinvestors.com Universal Ibogaine says 2023 will be pivotal year for the company and Canadians seeking ibogaine treatment Universal Ibogaine Inc (TSX-V:IBO) said it has laid the groundwork during 2022 to enter the new year positioned to advance its planned clinical trial involving semi-synthesized Ibogaine HCL (ibogaine…
proactiveinvestors.com Universal Ibogaine closes private placement, announces potential C$5M offering of convertible debt securities and shares Universal Ibogaine Inc (TSX-V:IBO) said it has closed its previously announced non-brokered private placement of convertible notes for the aggregate principal amount of C$626,500. The company said…
proactiveinvestors.ca Universal Ibogaine forms advisory board in support of mission to deliver medicalized ibogaine-centered addiction care Universal Ibogaine Inc (TSX-V:IBO) has formed an external advisory board as part of its strategic plans and mission to deliver medicalized ibogaine-centered addiction care and to undertake a planned…
proactiveinvestors.com Universal Ibogaine poised for offering to complete planned ibogaine-based clinical trial application Universal Ibogaine Inc (TSX-V:IBO) (UI) reported it was set to carry out an offering of convertible debt securities with net proceeds to be used to complete its planned ibogaine-based clinical trial…
proactiveinvestors.com Universal Ibogaine says Kelburn addiction recovery clinic to reopen on October 17, 2022 Universal Ibogaine Inc (TSX-V:IBO) has said its research and development clinic in Winnipeg, the Kelburn Mental Health and Addiction Recovery Centre, is scheduled to reopen and commence business…
proactiveinvestors.com Universal Ibogaine targets October re-opening of Kelburn addiction treatment facility near Winnipeg Universal Ibogaine Inc (TSX-V:IBO) said it is targeting early October for the re-opening of its Winnipeg addiction treatment facility, the Kelburn Recovery Centre, after it was closed in April due to…
proactiveinvestors.com Universal Ibogaine retains co-founder Shayne Nyquvest as capital markets advisor Universal Ibogaine Inc (TSX-V:IBO) told investors that it has retained Shayne Nyquvest in a consulting role as capital markets advisor. Nyquvest, a co-founder of the company, has extensive capital…